Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Net cash used in operating activities	$ (779,339)	$ (697,341)
Cash flows from investing activities
Acquisition of AEI		63,414
Investment in equipment	(1,638)	(4,913)
Investment in patents	(405)	(2,858)
Net cash provided by (used in) investing activities	(2,043)	55,643
Cash flows from financing activities
Payments on convertible notes	(37,500)	(195,000)
Proceeds from private placement offering	25,000
Net cash used in financing activities	(12,500)	(195,000)
Net change in cash	(793,882)	(836,698)
Cash and cash equivalents at beginning of period	1,276,654	1,980,015
Cash and cash equivalents at end of period	482,772	1,143,317
Supplemental Cash Flow Information
Cash paid for interest	727
Cash paid for income taxes
Non-Cash Transactions
Stock issued for accrued liabilities	93,250	77,250
Stock issued for advances from investors	25,000	721,033
Conversion of debt to common stock	100,000	178,125
Reversal of previously accrued dividend		$ 34,277